.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Dow
Boehringer Ingelheim
Accenture
Harvard Business School
Federal Trade Commission
McKesson
UBS
Novartis

Generated: June 22, 2017

DrugPatentWatch Database Preview

UNI-DUR Drug Profile

« Back to Dashboard

Which patents cover Uni-dur, and what generic Uni-dur alternatives are available?

Uni-dur is a drug marketed by Schering and is included in two NDAs.

The generic ingredient in UNI-DUR is theophylline. There are thirty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the theophylline profile page.

Summary for Tradename: UNI-DUR

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list84
Clinical Trials: see list30
Patent Applications: see list9,692
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:UNI-DUR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering
UNI-DUR
theophylline
TABLET, EXTENDED RELEASE;ORAL089822-001Jan 4, 1995DISCNNoNo► Subscribe► Subscribe
Schering
UNI-DUR
theophylline
TABLET, EXTENDED RELEASE;ORAL089823-001Jan 4, 1995DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Medtronic
Moodys
Covington
Boehringer Ingelheim
Healthtrust
McKesson
Mallinckrodt
Accenture
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot